IVD Medical Holding Limited

SEHK:1931 Voorraadrapport

Marktkapitalisatie: HK$2.8b

IVD Medical Holding Beheer

Beheer criteriumcontroles 2/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Kuk Sing Ho

Algemeen directeur

CN¥5.6m

Totale compensatie

Percentage CEO-salaris47.03%
Dienstverband CEO5.9yrs
Eigendom CEOn/a
Management gemiddelde ambtstermijn5.9yrs
Gemiddelde ambtstermijn bestuur3.6yrs

Recente managementupdates

Recent updates

IVD Medical Holding's (HKG:1931) Promising Earnings May Rest On Soft Foundations

May 07
IVD Medical Holding's (HKG:1931) Promising Earnings May Rest On Soft Foundations

IVD Medical Holding (HKG:1931) Is Doing The Right Things To Multiply Its Share Price

Dec 12
IVD Medical Holding (HKG:1931) Is Doing The Right Things To Multiply Its Share Price

IVD Medical Holding Limited's (HKG:1931) Shares Climb 29% But Its Business Is Yet to Catch Up

Oct 14
IVD Medical Holding Limited's (HKG:1931) Shares Climb 29% But Its Business Is Yet to Catch Up

Additional Considerations Required While Assessing IVD Medical Holding's (HKG:1931) Strong Earnings

Sep 27
Additional Considerations Required While Assessing IVD Medical Holding's (HKG:1931) Strong Earnings

IVD Medical Holding Limited's (HKG:1931) 30% Dip In Price Shows Sentiment Is Matching Earnings

Aug 17
IVD Medical Holding Limited's (HKG:1931) 30% Dip In Price Shows Sentiment Is Matching Earnings

Little Excitement Around IVD Medical Holding Limited's (HKG:1931) Earnings As Shares Take 38% Pounding

Jun 07
Little Excitement Around IVD Medical Holding Limited's (HKG:1931) Earnings As Shares Take 38% Pounding

These 4 Measures Indicate That IVD Medical Holding (HKG:1931) Is Using Debt Safely

May 22
These 4 Measures Indicate That IVD Medical Holding (HKG:1931) Is Using Debt Safely

IVD Medical Holding's (HKG:1931) Shareholders Will Receive A Bigger Dividend Than Last Year

Apr 25
IVD Medical Holding's (HKG:1931) Shareholders Will Receive A Bigger Dividend Than Last Year

IVD Medical Holding's (HKG:1931) Shareholders Will Receive A Bigger Dividend Than Last Year

Apr 03
IVD Medical Holding's (HKG:1931) Shareholders Will Receive A Bigger Dividend Than Last Year

IVD Medical Holding Limited's (HKG:1931) 28% Price Boost Is Out Of Tune With Earnings

Mar 30
IVD Medical Holding Limited's (HKG:1931) 28% Price Boost Is Out Of Tune With Earnings

IVD Medical Holding (HKG:1931) Is Paying Out A Larger Dividend Than Last Year

Mar 20
IVD Medical Holding (HKG:1931) Is Paying Out A Larger Dividend Than Last Year

If EPS Growth Is Important To You, IVD Medical Holding (HKG:1931) Presents An Opportunity

Mar 06
If EPS Growth Is Important To You, IVD Medical Holding (HKG:1931) Presents An Opportunity

IVD Medical Holding (HKG:1931) Is Doing The Right Things To Multiply Its Share Price

Feb 08
IVD Medical Holding (HKG:1931) Is Doing The Right Things To Multiply Its Share Price

Calculating The Fair Value Of IVD Medical Holding Limited (HKG:1931)

Oct 22
Calculating The Fair Value Of IVD Medical Holding Limited (HKG:1931)

IVD Medical Holding's (HKG:1931) Returns On Capital Are Heading Higher

Oct 01
IVD Medical Holding's (HKG:1931) Returns On Capital Are Heading Higher

IVD Medical Holding's (HKG:1931) Dividend Will Be Increased To CN¥0.0297

Aug 22
IVD Medical Holding's (HKG:1931) Dividend Will Be Increased To CN¥0.0297

IVD Medical Holding's (HKG:1931) Shareholders Will Receive A Bigger Dividend Than Last Year

Apr 05
IVD Medical Holding's (HKG:1931) Shareholders Will Receive A Bigger Dividend Than Last Year

IVD Medical Holding (HKG:1931) Is Increasing Its Dividend To CN¥0.0556

Mar 22
IVD Medical Holding (HKG:1931) Is Increasing Its Dividend To CN¥0.0556

Returns At IVD Medical Holding (HKG:1931) Are On The Way Up

Feb 16
Returns At IVD Medical Holding (HKG:1931) Are On The Way Up

Does IVD Medical Holding (HKG:1931) Have A Healthy Balance Sheet?

Oct 16
Does IVD Medical Holding (HKG:1931) Have A Healthy Balance Sheet?

Calculating The Intrinsic Value Of IVD Medical Holding Limited (HKG:1931)

Sep 28
Calculating The Intrinsic Value Of IVD Medical Holding Limited (HKG:1931)

IVD Medical Holding (HKG:1931) Has A Rock Solid Balance Sheet

May 16
IVD Medical Holding (HKG:1931) Has A Rock Solid Balance Sheet

IVD Medical Holding's (HKG:1931) Dividend Will Be Increased To HK$0.053

Apr 14
IVD Medical Holding's (HKG:1931) Dividend Will Be Increased To HK$0.053

IVD Medical Holding's (HKG:1931) Shareholders Will Receive A Bigger Dividend Than Last Year

Mar 23
IVD Medical Holding's (HKG:1931) Shareholders Will Receive A Bigger Dividend Than Last Year

IVD Medical Holding (HKG:1931) Is Doing The Right Things To Multiply Its Share Price

Mar 16
IVD Medical Holding (HKG:1931) Is Doing The Right Things To Multiply Its Share Price

IVD Medical Holding (HKG:1931) Is Experiencing Growth In Returns On Capital

Jul 30
IVD Medical Holding (HKG:1931) Is Experiencing Growth In Returns On Capital

These 4 Measures Indicate That IVD Medical Holding (HKG:1931) Is Using Debt Reasonably Well

May 04
These 4 Measures Indicate That IVD Medical Holding (HKG:1931) Is Using Debt Reasonably Well

There's Been No Shortage Of Growth Recently For IVD Medical Holding's (HKG:1931) Returns On Capital

Apr 20
There's Been No Shortage Of Growth Recently For IVD Medical Holding's (HKG:1931) Returns On Capital

IVD Medical Holding's (HKG:1931) Stock Price Has Reduced 44% In The Past Year

Mar 05
IVD Medical Holding's (HKG:1931) Stock Price Has Reduced 44% In The Past Year

Are IVD Medical Holding's (HKG:1931) Statutory Earnings A Good Guide To Its Underlying Profitability?

Feb 15
Are IVD Medical Holding's (HKG:1931) Statutory Earnings A Good Guide To Its Underlying Profitability?

Here's What IVD Medical Holding Limited's (HKG:1931) Shareholder Ownership Structure Looks Like

Jan 31
Here's What IVD Medical Holding Limited's (HKG:1931) Shareholder Ownership Structure Looks Like

A Look At The Fair Value Of IVD Medical Holding Limited (HKG:1931)

Jan 16
A Look At The Fair Value Of IVD Medical Holding Limited (HKG:1931)

Does IVD Medical Holding (HKG:1931) Have The Makings Of A Multi-Bagger?

Jan 01
Does IVD Medical Holding (HKG:1931) Have The Makings Of A Multi-Bagger?

How Does IVD Medical Holding Limited (HKG:1931) Fare As A Dividend Stock?

Dec 17
How Does IVD Medical Holding Limited (HKG:1931) Fare As A Dividend Stock?

Have Insiders Been Buying IVD Medical Holding Limited (HKG:1931) Shares This Year?

Dec 02
Have Insiders Been Buying IVD Medical Holding Limited (HKG:1931) Shares This Year?

IVD Medical Holding's(HKG:1931) Share Price Is Down 28% Over The Past Year.

Nov 19
IVD Medical Holding's(HKG:1931) Share Price Is Down 28% Over The Past Year.

Analyse CEO-vergoeding

Hoe is Kuk Sing Ho's beloning veranderd ten opzichte van IVD Medical Holding's winst?
DatumTotale vergoedingSalarisBedrijfswinsten
Dec 31 2024CN¥6mCN¥3m

CN¥260m

Sep 30 2024n/an/a

CN¥260m

Jun 30 2024n/an/a

CN¥260m

Mar 31 2024n/an/a

CN¥249m

Dec 31 2023CN¥4mCN¥4m

CN¥238m

Sep 30 2023n/an/a

CN¥235m

Jun 30 2023n/an/a

CN¥232m

Mar 31 2023n/an/a

CN¥221m

Dec 31 2022CN¥5mCN¥4m

CN¥210m

Sep 30 2022n/an/a

CN¥193m

Jun 30 2022n/an/a

CN¥177m

Mar 31 2022n/an/a

CN¥176m

Dec 31 2021CN¥4mCN¥4m

CN¥175m

Compensatie versus markt: De totale vergoeding ($USD 778.41K ) Kuk Sing } ligt boven het gemiddelde voor bedrijven van vergelijkbare omvang in de Hong Kong markt ($USD 445.54K ).

Compensatie versus inkomsten: De vergoeding van Kuk Sing is het afgelopen jaar met meer dan 20% gestegen.

CEO

Kuk Sing Ho (65 yo)

5.9yrs

Tenure

CN¥5,614,000

Compensatie

Mr. Ho Kuk Sing serves as Executive Director, Chairman of the Board and Chief Executive Officer at IVD Medical Holding Limited since June 21, 2019. He was Director of IVD Medical Holding Limited since May...

Leiderschapsteam

NaamPositieTenureCompensatieEigendom
Kuk Sing Ho
Chairman & CEO5.9yrsCN¥5.61mgeen gegevens
Kim Fai Law
CFO, Company Secretary & Executive Director1.2yrsCN¥849.00kgeen gegevens
Xianya Lin
GM & Executive Director5.9yrsCN¥4.09m0.88%
HK$ 25.0m
Siu Kei Ken Chan
Executive Director1.2yrsCN¥431.00kgeen gegevens
Bo Yang
Financial Controller9.3yrsgeen gegevensgeen gegevens

5.9yrs

Gemiddelde duur

48yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van 1931 is doorgewinterd en ervaren (gemiddelde ambtstermijn van 5.9 jaar).

Bestuursleden

NaamPositieTenureCompensatieEigendom
Kuk Sing Ho
Chairman & CEO9yrsCN¥5.61mgeen gegevens
Kim Fai Law
CFO, Company Secretary & Executive Director1.2yrsCN¥849.00kgeen gegevens
Xianya Lin
GM & Executive Director9.3yrsCN¥4.09m0.88%
HK$ 25.0m
Siu Kei Ken Chan
Executive Director1.2yrsCN¥431.00kgeen gegevens
Sze Lok Wong
Independent Non-Executive Director1.2yrsCN¥251.00kgeen gegevens
Renqian Zhong
Independent Non-Executive Director5.9yrsCN¥120.00kgeen gegevens
Ka Sing Leung
Independent Non-Executive Director5.9yrsCN¥120.00kgeen gegevens
Haiyun Yao
Non-Executive Director3.6yrsgeen gegevensgeen gegevens
Fei Liu
Non-executive Director1.2yrsgeen gegevensgeen gegevens

3.6yrs

Gemiddelde duur

51yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van 1931 wordt beschouwd als ervaren (gemiddelde ambtstermijn 3.6 jaar).

Bedrijfsanalyse en status van financiële gegevens

GegevensLaatst bijgewerkt (UTC-tijd)
Bedrijfsanalyse2025/05/19 21:58
Aandelenkoers aan het einde van de dag2025/05/19 00:00
Inkomsten2024/12/31
Jaarlijkse inkomsten2024/12/31

Gegevensbronnen

De gegevens die gebruikt zijn in onze bedrijfsanalyse zijn afkomstig van S&P Global Market Intelligence LLC. De volgende gegevens worden gebruikt in ons analysemodel om dit rapport te genereren. De gegevens zijn genormaliseerd, waardoor er een vertraging kan optreden voordat de bron beschikbaar is.

PakketGegevensTijdframeVoorbeeld Amerikaanse bron *
Financiële gegevens bedrijf10 jaar
  • Resultatenrekening
  • Kasstroomoverzicht
  • Balans
Consensus schattingen analisten+3 jaar
  • Financiële prognoses
  • Koersdoelen analisten
Marktprijzen30 jaar
  • Aandelenprijzen
  • Dividenden, splitsingen en acties
Eigendom10 jaar
  • Top aandeelhouders
  • Handel met voorkennis
Beheer10 jaar
  • Leiderschapsteam
  • Raad van bestuur
Belangrijkste ontwikkelingen10 jaar
  • Bedrijfsaankondigingen

* Voorbeeld voor effecten uit de VS, voor niet-Amerikaanse effecten worden gelijkwaardige formulieren en bronnen gebruikt.

Tenzij anders vermeld zijn alle financiële gegevens gebaseerd op een jaarperiode, maar worden ze elk kwartaal bijgewerkt. Dit staat bekend als Trailing Twelve Month (TTM) of Last Twelve Month (LTM) gegevens. Meer informatie.

Analysemodel en Snowflake

Details van het analysemodel dat is gebruikt om dit rapport te genereren, zijn beschikbaar op onze Github-pagina. We hebben ook handleidingen voor het gebruik van onze rapporten en tutorials op Youtube.

Leer meer over het team van wereldklasse dat het Simply Wall St-analysemodel heeft ontworpen en gebouwd.

Industrie en sector

Onze industrie- en sectormetrics worden elke 6 uur berekend door Simply Wall St, details van ons proces zijn beschikbaar op Github.

Bronnen van analisten

IVD Medical Holding Limited wordt gevolgd door 1 analisten. 0 van deze analisten hebben de schattingen van de omzet of winst ingediend die zijn gebruikt als input voor ons rapport. Inzendingen van analisten worden de hele dag door bijgewerkt.

AnalistInstelling
Yue-Kwong LuiJefferies LLC